News - HealthQuill

A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World Health Organization has not observed “unusual outbreak patterns.”

Respiratory infections in China have no ‘unusual outbreak patterns’

A rise in cases of respiratory infections in China is within the expected range during this time of the year, and the World.

by HealthQuill
January 8, 2025
0 Comments

Johnson & Johnson’s combination therapy for treating a certain form of cancer without chemotherapy, has been shown to extend patients' lives by more than a year, according to a company statement.

Drugs Health Medical Pharma

J&J’s combination extends lives of cancer patients versus rival drug

Johnson & Johnson’s combination therapy for treating a certain form of cancer without chemotherapy, has been shown to extend patients' lives by more.

by HealthQuill
January 8, 2025
0 Comments

Climate Health Research

Digital monitoring fails to boost remote worker productivity, new study finds

Post-pandemic, the Hamlet-like dilemma of ‘work from office or work from home’ has led to a battle of push and pull. Many corporates.

by HealthQuill
January 7, 2025
0 Comments

Dancing has a positive effect on the “mood circuits” in the brain and can lower depression in people with Parkinson’s disease, according to an observational study on 23 patients conducted by Canada’s York University.

Drugs Health Medical

Dancing can help lower depression in people with Parkinson’s disease

Dancing has a positive effect on the “mood circuits” in the brain and can lower depression in people with Parkinson’s disease, according to.

by HealthQuill
January 7, 2025
0 Comments

China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight cancer for an upfront payment of $925 million.

Drugs Medical Pharma

WuXi Biologics sells global rights to cancer antibody to Candid for $925m

China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight.

by HealthQuill
January 7, 2025
0 Comments

US-based medical device maker Stryker Corporation will acquire Inari Medical Inc., for about $4.9 billion to expand the former’s neurovascular business.

Drugs Medical Pharma

Stryker to buy Inari for $4.9b to expand neurovascular business

US-based medical device maker Stryker Corporation will acquire Inari Medical Inc., for about $4.9 billion to expand the former’s neurovascular business.

by HealthQuill
January 7, 2025
0 Comments

Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.

Health Medical

Surge in HMPV cases in China raises worldwide alarm

Bharti Jayshankar January 6, 2024: Reports of a surge of Human Metapneumovirus (HMPV), a respiratory virus, cases in China have left the world.

by HealthQuill
January 6, 2025
0 Comments

Health Medical Research

Understanding the social determinants of suicide mortality

HQ Team January 6, 2025: Suicide remains a pressing global public health issue, with over 700,000 deaths annually. A recent study highlighted significant social determinants.